MAXD INVEST @MAXDinvest $MAXD Shareholder, Our forecasted revenue from InGround Assets signed deals + Biometric, and licensed tech, starts $100,000,000 run-rate in Q4 '22. The chart below 2023-24 we add $250,000,000 more & 2024-25 we add $475,000,000. Exciting times for $MAXD! More news on the way!
Emergent Biosolutions (NYSE:EBS) – makes a proven smallpox vaccine that may be used for monkeypox Bavarian Nordic (OTCMKTS:BVNRY) – boasts a monkeypox vaccine approved in the U.S. Inovio Pharmaceuticals (NASDAQ:INO) – reported minor vaccine progress SIGA Technologies (NASDAQ:SIGA) – recently received a thumbs up from the U.S. Food and Drug Administration (FDA) Tonix Pharmaceuticals (NASDAQ:TNXP) – has a promising smallpox vaccine in its pipeline Geovax Labs (NASDAQ:GOVX) – seeks to treat both Covid-19 and monkeypox with one vaccine Chimerix (NASDAQ:CMRX) – recently sold its smallpox drug to Emergent It’s a new week and monkeypox cases are increasing. Usually found in Africa, cases have recently cropped up in the United States, Canada and Europe. Recently, The New York Times reported 92 confirmed cases as of May 21, as well as “28 suspected cases” across 12 countries outside of Africa.
Recently, President Joe Biden addressed the Osan Air Base in South Korea and discussed the virus. He stressed that “it is something that everybody should be concerned about.”
Several companies are responding to this concern, however, working hard to provide monkeypox vaccines. Just as Covid-19 gave rise to a new vaccine boom, this new outbreak may also soon send a new group of biotech stocks upward. In fact, some companies have also already made progress on monkeypox vaccines. BVNRY stock surged last week after Bavarian Nordic received U.S. and European orders for its vaccine. Now, other monkeypox stocks are moving as vaccine progress thrusts them into the spotlight.
Let’s take a look at these seven monkeypox stocks to watch.
EBS Emergent Biosolutions $33.77 BVNRY Bavarian Nordic $8.38 INO Inovio Pharmaceuticals $1.80 SIGA SIGA Technologies $9.32 TNXP Tonix Pharmaceuticals $2.21 GOVX Geovax Labs $2.80 CMRX Chimerix $1.88 Monkeypox Stocks to Watch: Emergent Biosolutions (EBS) This biopharma company is known for producing ACAM2000, a vaccine proven to be effective at treating smallpox in high-risk patients. Reports indicate that the vaccine may also work against monkeypox. The Centers for Disease Control and Prevention (CDC) notes the following:
Market Data 
Markets 
AI
